期刊文献+

难治性癫痫患儿生酮饮食治疗依从性影响因素的调查分析 被引量:7

Influent factors on treatment compliance among intractable epilepsy children with ketogenic diet therapy
暂未订购
导出
摘要 目的调查研究难治性癫痫患儿生酮饮食治疗的依从性及其影响因素,寻找有针对性的干预措施,提高生酮饮食的依从性,以获得治疗最佳疗效。方法利用自行设计的调查表,对2010年1月~2011年5月在我院神经内科住院进行生酮饮食治疗的80例难治性癫痫患儿家长进行问卷调查及随访跟踪,了解其遵医行为,分析生酮饮食治疗依从性的影响因素。结果患儿家长的疾病相关知识认知程度、对治疗的信心与决心是影响生酮饮食治疗依从性的主要因素。结论患儿家长的疾病相关知识的认知程度及对治疗的信心与决心是影响治疗依从性的主要原因。因此应加强对患儿及家长的健康教育与心理干预,提高患儿家长的疾病认知程度,搭建医护患沟通平台,建立良好的医护患关系,增强其对治疗的信心与决心,提高治疗依从性,改善治疗效果。 Objective To explore the influent factors on treatment compliance among intractable epilepsy children with ketogenic diet therapy.Methods The investigation was carried out in 80 intractable epilepsy cases with ketogenic diet by using self-designed questionnaire.The data were analyzed to find out the influent factors on treatment compliance.Results It was significantly alleviated on parents' awareness of diseases,the confidence and determination on treatment.Conclusions The levels of dietary compliance are mainly affected by parents' awareness of diseases,the confidence and determination.Systematic health education should be taken to improve the parental awareness and confidence,thereby,improving the treatment compliance and the effect of treatment.
机构地区 深圳市儿童医院
出处 《齐齐哈尔医学院学报》 2012年第24期3421-3423,共3页 Journal of Qiqihar Medical University
基金 深圳市卫生局科技项目(项目编号:201003146)
关键词 难治性癫痫 生酮饮食 依从性 影响因素 Intractable epilepsy Ketogenic diet Compliance Influent factors
  • 相关文献

参考文献6

二级参考文献50

  • 1廖建湘,陈乾,秦炯,林庆,KurtE.Hecox.小儿难治性癫癎的手术治疗[J].实用儿科临床杂志,2005,20(10):1042-1044. 被引量:2
  • 2Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy[ J]. Pediatr Neurol,2006,35 ( 1 ) : 1 - 5.
  • 3Hartman ALiVining EP. Clinical aspects of the ketogenic diet[ J]. Epilepsia,2007,48( 1 ) :31 -42.
  • 4Kossoff EH, Laux LC, Blackford R, et al. When do seizures usually improve with the ketogenic diet [ J ] ? Epilepsia,2008,49 ( 2 ) : 329 - 333.
  • 5Mosek A, Natour H, Neufeld MY, et al. Ketogenic diet treatment in adults with refractory epilepsy: A prospective pilot study [ J ]. Seizure, 2009,18( 1 ) :30 -33.
  • 6Kossoff EH, Dorward JL. The modified Atkins diet[ J]. Epilepsia,2008, 49(8) :37 -41.
  • 7Kossoff EH, Turner Z, Bluml RM, et al. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet[ J]. Epilepsy Behav ,2007,10 ( 3 ) :432 - 436.
  • 8Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet [ J]. Epilepsia ,2007,48( 1 ) :43 -58.
  • 9Kim DY, Rho JM. The ketogenic diet and epilepsy [ J ]. Curr Opin Clin Nutr Metab Care,2008,11 : 113 - 120.
  • 10Ma W, Berg J, Yellen G. Ketogenic diet metabolites reduce firing in central neurons by opening KATP channels [ J ]. J Neurosci, 2007,27 (14) :3618 -3625.

共引文献45

同被引文献45

  • 1葛卫红.共情护理对剖宫产产妇焦虑情绪及护理满意度的影响[J].世界最新医学信息文摘,2019,0(95):288-289. 被引量:3
  • 2肖波,刘献增,龙小艳,等.癫痫治疗学[M].北京.人民卫生出版社,2010:163-170.
  • 3廖建湘.生酮饮食在儿童癫治疗中的应用进展[J].实用儿科临床杂志,2007,22(24):1847-1849. 被引量:20
  • 4Walker M C. Diagnosis and treatment of nonconvulsive status epilepticus [ J ]. CNS Drugs, 2001,15 ( 12 ) : 931- 939.
  • 5Visweswari G, Siva P K, Lokanatha V, et al. The antiep- ileptic effect of centella asiatica on the activities of Na ~/ K ~ , Mg2~ and Ca2~ -ATPases in rat brain during pentyle- netetrazol-induced epilepsy ~ J ]. Indian J Pharmacol, 2010,42(2) :82-86.
  • 6Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of p-glycoprotein and multidrug re- sistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis [ J ]. Epilepsy Res, 2006,68 ( 3 ) : 213-228.
  • 7Furuno T, Landi M T, Ceroni M, et al. Expression poly- morphism of the blood-brain barrier component p-glyco- protein (mdrl) in relation to parkinson ~s disease [ J ]. Pharmacogenetics, 2002,12 ( 7 ) :529-534.
  • 8Long Q, Qiu B, Liu W, et al. Functional recovery and neuronal regeneration of a rat model of epilepsy by trans- plantation of hesl-down regulated bone marrow stromal cells[ J]. Neuroscienee, 2012,212:214-224.
  • 9Koo D L, Joo E Y, Kim D, et al. Effects of levetiracetam as a monotherapy on bone mineral density and biochemi- cal markers of bone metabolism in patients with epilepsy [J]. Epilepsy Res, 2013,104(1-2) :134-139.
  • 10Wheless J W, Clarke D F, Arzimanoglou A. Treatment of pediatr epilepsy : European expert opinion,2007 [ J ]. Epi- leptic Disorders, 2007,22(4) :353-412.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部